IMC Chicago LLC bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 40,660 shares of the company’s stock, valued at approximately $3,806,000. IMC Chicago LLC owned about 0.63% of Direxion Daily S&P Biotech Bull 3x Shares at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in LABU. Squarepoint Ops LLC lifted its position in Direxion Daily S&P Biotech Bull 3x Shares by 33.2% during the 2nd quarter. Squarepoint Ops LLC now owns 161,146 shares of the company’s stock worth $9,171,000 after buying an additional 40,157 shares in the last quarter. Ethos Financial Group LLC increased its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 33.5% in the second quarter. Ethos Financial Group LLC now owns 9,055 shares of the company’s stock valued at $515,000 after acquiring an additional 2,270 shares during the last quarter. RBF Capital LLC bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the second quarter worth about $378,000. McGuire Investment Group LLC boosted its position in Direxion Daily S&P Biotech Bull 3x Shares by 30.2% during the third quarter. McGuire Investment Group LLC now owns 6,547 shares of the company’s stock valued at $613,000 after purchasing an additional 1,519 shares during the last quarter. Finally, Allworth Financial LP boosted its position in Direxion Daily S&P Biotech Bull 3x Shares by 1,777.8% during the second quarter. Allworth Financial LP now owns 4,225 shares of the company’s stock valued at $240,000 after purchasing an additional 4,000 shares during the last quarter.
Direxion Daily S&P Biotech Bull 3x Shares Stock Down 10.9%
NYSEARCA:LABU opened at $149.04 on Friday. Direxion Daily S&P Biotech Bull 3x Shares has a twelve month low of $32.55 and a twelve month high of $198.18. The stock’s 50 day moving average price is $166.88 and its two-hundred day moving average price is $120.20.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Featured Articles
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Your Bank Account Is No Longer Safe
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- When to buy gold (mathematically)
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
